You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,772,473


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,772,473
Title: Nitrofurantoin dosage form
Abstract:The invention involves a combination sustained release/rapid release pharmaceutical capsule for oral administration of nitrofurantoin comprising, in a capsule shell, a first layer of a first particulate mixture comprising nitrofurantoin, polyvinylpyrrolidone and carboxyvinylpolymer; and a second layer of a second particulate mixture comprising macrocrystalline nitrofurantoin.
Inventor(s): Patel; Vikram S. (Norwich, NY), Welles; Harry L. (Norwich, NY)
Assignee: Norwich Eaton Pharmaceuticals, Inc. (Norwich, NY)
Application Number:06/874,943
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex landscape of U.S. patents, it is crucial to understand the scope and claims of a patent, as these elements determine the patent's validity, enforceability, and overall value. This article will delve into the key aspects of patent scope and claims, using the example of U.S. Patent 4,772,473 to illustrate these concepts.

What is a Patent?

A patent is a government-granted monopoly that gives the inventor the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[2].

Patent Scope

The scope of a patent is defined by its claims, which are the legally binding descriptions of the invention. The patent scope is a critical factor in determining the breadth of protection afforded to the inventor.

Metrics for Measuring Patent Scope

Researchers have proposed several metrics to measure patent scope, including independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims

Patent claims are the heart of a patent application, as they define the invention and the scope of protection.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Construction

The process of interpreting the meaning of patent claims is known as claim construction. This is often a critical step in patent litigation, as it determines the scope of the patent's protection. For example, in the case of Contour IP Holding LLC v. GoPro, Inc., the court had to construe disputed claim terms to determine whether GoPro's products infringed on Contour's patents[2].

Patent Eligibility

Patent eligibility is a fundamental aspect of the patent system, ensuring that only inventions that meet certain criteria are granted patents.

Section 101 of the Patent Act

Section 101 of the Patent Act states that patents may be obtained for "any new and useful process, machine, manufacture, or composition of matter, or any improvement thereof." However, certain exceptions exist, such as laws of nature, natural phenomena, and abstract ideas[2].

The Alice Test

The Supreme Court's Alice decision established a two-step test to determine whether patent claims are directed to patent-ineligible subject matter. Step one involves determining if the claims are directed to an abstract idea. If so, step two assesses whether the claims include elements that transform the abstract idea into a patent-eligible application[2].

The 2024 USPTO Guidance Update on AI Patents

Recent updates to USPTO guidance, effective July 17, 2024, provide clarity on the patent eligibility of AI-related inventions. This guidance emphasizes the integration of judicial exceptions into practical applications and ensures that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution[4].

Case Study: U.S. Patent 4,772,473

While the specific details of U.S. Patent 4,772,473 are not provided here, we can apply the general principles discussed above to understand its scope and claims.

Claim Analysis

To analyze the claims of U.S. Patent 4,772,473, one would need to:

  • Identify the independent and dependent claims.
  • Determine the breadth and specificity of these claims.
  • Assess whether the claims meet the criteria for patent eligibility under Section 101 and the Alice test.

Scope Determination

The scope of U.S. Patent 4,772,473 would be determined by the language of its claims. Narrower claims would generally provide clearer and more focused protection, while broader claims might face challenges during the examination process or in litigation[3].

Trends in Patent Allowance Rates

The allowance rate for patent applications has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications." This trend highlights the increasing scrutiny of patent applications and the importance of well-crafted claims[1].

Key Takeaways

  • Patent Scope: Defined by the claims, which must be clear and specific to ensure strong protection.
  • Claim Construction: Critical in determining the scope of protection and often a focal point in patent litigation.
  • Patent Eligibility: Ensures that only inventions meeting certain criteria are granted patents, with recent updates clarifying the process for AI-related inventions.
  • Trends in Allowance Rates: The decreasing allowance rate underscores the need for high-quality, well-defined patent applications.

FAQs

What is the significance of patent claims in a patent application?

Patent claims are the legally binding descriptions of the invention and define the scope of protection afforded to the inventor.

How does the Alice test impact patent eligibility?

The Alice test is a two-step process that determines whether patent claims are directed to patent-ineligible subject matter, such as abstract ideas, and whether the claims include elements that transform the abstract idea into a patent-eligible application.

What are the key metrics for measuring patent scope?

Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope, as they correlate with several indicators of patent quality.

How has the 2024 USPTO guidance update affected AI-related patents?

The update clarifies the process for determining the patent eligibility of AI-related inventions, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies and providing practical examples for patent eligibility analysis.

What is the current trend in patent allowance rates?

The patent allowance rate has decreased over time, particularly in certain technology fields, highlighting the increasing scrutiny of patent applications and the importance of well-crafted claims.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Contour IP Holding LLC v. GoPro, Inc. (2024). United States Court of Appeals for the Federal Circuit.
  3. Patent Claims and Patent Scope (2016). SSRN.
  4. Understanding the 2024 USPTO Guidance Update on AI Patent (2024). Mintz.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,772,473

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.